Revakinagene taroretcel

Revakinagene taroretcel, sold under the brand name Encelto, is an allogeneic encapsulated cell-based gene therapy used for the treatment of macular telangiectasia type 2. Revakinagene taroretcel is administered into the recipient's eye during a single surgical procedure.